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 125I-Bolton-Hunter labeled tachykinins, substance P, neuro-
kinin A, and eledoisin have been used as radioligands to 
differentiate multiple tachykinin receptors 11),12),30). 125I-Bolton-
Hunter substance P seems to be a radioligand predominantly 
recognizing NK1 subtype of tachykinin receptors. As de-
scribed here, using the quantitative receptor autoradio-
graphic method, the binding sites specifically labeled with 
the radioligand can be vigorously analyzed. In addition to 
substance P, neurokinin A and neurokinin B known to be 
endogenously, new tachykinins, neuropeptide K31) and 
neuropeptide R32) have been isolated from the porcine brain 
and rabbit small intestine, respectively. Further characteris-
tics of tachykinin receptors would be clarified with the 
method described.
Introduction 
 Substance P, a member of tachykinin family peptides 
with an amino acid sequence, -Phe-X-Gly-Leu-Met-NH2 at 
the C-terminus in common acts as a sensory-neurotrans-
mitter in the central and peripheral nervous system, by 
interacting with specific receptors present on the mem-
brane surface. The receptors for tachykinins are currently 
classified into three subtypes of neurokinin (NK )1, NK2 and 
NK3, presumably recognizing substance P, neurokinin A 
and neurokinin B, respectively 1,2', as the molecular struc-
tures were recently determined"','). 125I-Bolton-Hunter sub-
stance P, a compound of the peptide of which the Lys3 
residue is conjugated with monoiodinated 125I-Bolton-
Hunter reagents' was found to be a radioligand and was 
used to detect specific receptor for substance P in the rat 
parotid cell and brain cortex membranes"'. Accumulating 
evidence revealed that the compound is a suitable 
radioligand in the receptor autoradiographic techniques 
used to detect specific receptor of substance P9•lo,ll' Among 
three subtypes of tachykinin receptors, NK, receptor 
seems to be predominantly recognized by "I-Bolton-Hunter 
substance P1,12.13) 
 This chapter describes our quantitative receptor 
autoradiographic method for specific 125I-Bolton-Hunter
substance P binding sites, functional sites of tachy-
kinins14,15,16,17). As we previously found in the case of I'll-
[ Sarl]-angiotensin 11 18', based on the original technique for 
benzodiazepine receptors with 3 H-ligands19' , the method 
with 125I-ligands coupled to computerized microdensito-
metry, and a comparison with 1251-standards makes feasible 
the quantitative determination and complete characteriza-
tion of neuropeptides receptors in tissues from a single 
animal. The techniques have advantages over receptor 
binding assays with partially purified membrane prepara-
tions, including precise anatomical localization and a 
several fold increase in sensitivity. The method with '9-
ligands also surpasses that with 3H-ligands in quantita-
tion, since tissue quenching of radioisotope energy of 'H is 
linked to the failure to attain precise quantitations of 
receptors in myelin-rich areas such as brain white 
matter","). Furthermore, as the use of 1251-ligands, the final 
results can be obtained within a week of the binding 
experiments and rapid data collection is feasible.
Basic- Methodology 
Preparation of 1251-standards 
1. Add known amounts of increasing concentrations of 
   125I-labeled compounds to rat brain tissue aliquots 
   previously ground to a paste in a centrifuge tube. 
2. Homogenize with a polytron homogenizer to mix 
   thoroughly. 
3. Transfer homogenate to a small tube, and then centrif-
   uge at 3000 rpm for 10 min to degass. 
4. Freeze the tube on dry ice, and remove frozen paste 
   from the tube. 
5. Cut 16,u m thick* 1 sections in a cryostat at -16 1C, and 
   thaw-mount the sections onto subbed glass slides*'. 
6. Desiccate the sections under vacuum at 4C. 
7. Store the standard sections in a desiccator. 
8. Sets of standards obtained from consecutive sections 
   are used for determination of protein concentrations
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   and for radioactivity. 
 The method was originally described for 'H-standards by 
Unnerstall et al."' The '25I-standards made of polymer are 
available from Amersham Laboratories, England. When 
the concentration of binding sites have to be calculated as 
an amount of radioligand specifically bound (i.e., fmol) 
per mg protein, it is necessary to convert the data ex-
pressed as fmol/mg weight to fmol/mg protein, by com-
paring the standard curves obtained from commercially 
available polymer standards with those from the stan-
dards, as described'). 
 *' Thickness of the standards should be the same as of 
tissues sections. 
  *2 Glass slides are soaked in alconox solution , removed 
from the solution and boiled gently in deionized water for 
1 hr, then washed three times and soaked in 80% alcohol 
overnight. The slides were soaked overnight in deionized 
water and dipped in a freshly made gelatin subbing solu-
tion (2.5 g gelatin powder and 250 mg chromium sulfate in 
500 ml distilled water), dried overnight in a 371C oven, and 
stored in dust-free slide boxes. 
Determination of the characteristics curve of the film 
 Prior to the quantitation of binding sites specifically 
labeled by 125I-ligands, the characteristic curve of the film
used has to be determined from the optical densities 
obtained with different exposure times of the same set of 
125I-standards . Our data obtained using 'H-Ultrofilm is 
shown in the left side of Fig. 11e'. The curve was generated 
by the semilog plot of the optical densities read from the 
filmvs the product of the amount of radioactivity present 
in each standard and the exposure time. As shown in Fig. 
1, the characteristic curve of " I-standards and 3 H-
Ultrofilm was similar to that of 3H-standards. The slope 
of the curve gives a measure of the photographic contrast. 
At an optical density of 0.2 unit or less, the changes in the 
slope as a function of exposure time are very small, and 
discrimination between different values is difficult. At an 
optical density of 0.2 unit or less, the changes in the slope 
as a function of exposure time are very small, and dis-
crimination between different values is difficult. At 
optical densities greater than 1.6 units, the film rapidly 
saturates and no useful data can be obtained. A linear 
relationship ( y = 0.934) exists between optical density 
and dpm/pg of protein x time of exposure for values 
between 0.3 and 1.6 optical density units. In this case, the 
contrast is high between different optical densities values, 
making it easy to discriminate between small differences 
in concentration of radioactivity, i.e. between different 
concentrations of binding sites for a particular structure. 
With this information, the exposure time which produces
Fig. 1. Quantitative autoradiographic technique for 125I-ligands. Right Panel : A In-ln plot of O.D. vs. radioactivity (dpm/,ug 
protein) in standards. Exposure times were 1 (0) and 2 (0) days. Each point represents the average of three optical density 
readings from autoradiographs generated from triplicate standard curves and prepared for each film utilized for the 
quantitation of A II receptors. Dashed lines represent the stndard error of estimate of X from Y. The general equation of the 
straight line was, for 24 pairs of data : Y = 0.757 X = -2.76 ; g = 0.84 ; F = 68.4 (P<0.001). Left panel : Characteristic curve of 
['H] Ultrofilm with 125I-standards. Optical densities are plotted as a function of In of dpm/,u g protein x exposure time. Each 
point represents the average of three optical density readings from autoradiograms generated from triplicate standard curves. 
[Reproduced with permission from Ref. 23.]
the optimal contrast can be estimated for a particular 
tissue section. It is therefore desirable, in preliminary 
experiments, to expose the labeled tissue sections for 
varying lengths of time to determine the adequate condi-
tions for optimum contrast (optical densities between 0.6 
and 1.4 units for each particular structure). 
"I -standard curves 
 Based on the data from the characteristics curves 
determined as described above, 'I-standard curves can be 
obtained. The curve shown in the right side of Fig. 1 was 
calculated by measuring the optical densities of the 
autoradiogram (right side in Fig. 2) obtained from each 
set of standards contained concentration of radioactivity/ 
,u g protein varying from 9.17 to 1008 dpm, after 4 days 
exposure to 3H-Ultrofilm. There was a linear relationship 
between the In of optical densities and the In of the 
concentration of radioactivity at any exposure of ' H-
Ultrofilm to the standards. As shown in Fig. 2, tissue 
sections labeled in vitro by 9-ligands were placed together 
with "I-standards in a X-ray cassettes and opposed 
against the film. *'The molar quantities of ligand bound/ 
mg protein of tissue were determined by interpolating the 
optical density in the straight line obtained from the In-In 
standard curve and correcting according to the equation : 
[mmol/Ci (spec. act.)]x [1 Ci/2.22 x 10" dpm] x 103 =
fmol/mg protein. 
 `As the method with "I -ligands led to the first quanti-
tation of '25I-[Sar' ]-angiotensin II binding sites"), the 
figure of specific angiotensin II binding sites in the rat 
adrenal gland previously published was presented, as an 
example".
In Vitro Labeling of Tissue Sections with 125I-
Bolton-Hunter Substance P 
Tissue preparation 
 Animal tissues rapidly removed or human tissues 
obtained at autopsy are frozen by immersion in isopentane 
at -30°C. Frozen tissues can be stored in air-tight bags at 
-80'C . Frozen, 16 p m-thick sections are cut in a cryostat 
at -14°C, thaw-mounted onto glass slides, and dried under 
vacuum in cold room at 4°C overnight. After tissue sec-
tions are dried, slides are transferred to boxes in the cold 
room, and the boxes are hermetically sealed. 
Preincubation 
 When the slides are transferred from boxes to stainless 
steel racks, care must be taken to prevent exposure to 
humidity. The boxes are left at room temperature, and
Fig. 2. Angiotensin II receptors in rat adrenal gland. Left panel : 1, 2 and 3. Rat adrenal gland (16pm sections) incubated 
with 5.0, 1.25 and 0.32 nM 'a5I-[Sar']-A II . Arrows point to zona glomerulosa and to adrenal medulla. 4. Adjacent section 
incubated with 5 nM 'a5I-[Sar1]-AII and 25 P M unlabeled A II . Right panel : Autoradiographic image of 125I-standards with 
computerized densitometry. Each section contains a different amount of radioactivity per mg of protein. In dpm : A, 9.17 ; B, 
20.8; C, 72.8 D, 200.5; E, 536.4; F, 1008.0. [Reproduced with permission from Ref. 23.]
opened to transfer the slides to stainless steel racks. 
 Tissue sections dried are first preincubated for 5 min at 
room temperature in 50 mM Tris-Hcl buffer, containing 
0.2 mg/ml bovine serum albumin (BSA) and 0.005% (vol/ 
vol) polyethylenimine, and then preincubated for 10 min in 
the same buffer without polyethylenimine14'. As described 
by Mantyh et al!'), polyethylenimine at the concentration 
of 0.005% prohibits the radioligands to bind nonspecifi-
cally to the glass. 
Incubation 
 After preincubation, tissue sections are labeled in vitro 
with '25I-Bolton-Hunter substance P. The sections on slides 
are incubated at room temperature for 90 min with the 
radioligand in an incubation box containing incubation 
buffer, 50 mM Tris-Hcl buffer, pH 7.4, 0.2 mg/ml BSA, 
40y g/ml bacitracin, 4,u g/ml leupeptn, 50,u g/ml chy-
mostatin, and 5 mM MnCl2 1454). The binding sites can be 
characterized using consecutive tissue sections. For exam-
ple, in the equilibrium binding study, consecutive tissue 
sections are incubated in the presence of increasing concen-
trations of "I-Bolton-Hunter substance P, and a fixed 
amount of unlabeled substance P. In displacement experi-
ments to examine specificity of the binding sites, the 
sections are incubated in the presence of increasing concen-
trations of unlabeled tachykinins and related peptides, and 
a fixed amount of "I-Bolton-Hunter substance P. 
1251-Au t oradiography 
 After incubation, the slides are washed four times for 30 
sec each in ice-cold 50 mM Tris-HC1 buffer and dried under 
a stream of air. If necessary, the tissue sections on slides 
are dried in an air-tight desiccator overnight. The slides 
are placed in X-ray film cassettes along with "I-standards, 
and opposed against 3H-Ultrofilm (LKB industries) or 
Hyperfilm-3H (Amersham) at room temperature. After 
adequate exposure, the films are developed at 201C for 4 
min with undiluted D19 Kodak developer. A complete set 
of "I-standards has to be processed with every cassettes 
and developed with every film. 
Data analysis 
 Optical densities are measured by computerized micro-
densitomery in both '25I-standards and specific areas of 
tissue sections from each film. After determination of the
Fig. 3. Receptor autoradiographic evidence of '25I-Bolton-Hunter substance P binding sites in rat celiac sympathetic ganglia, 
exposure time 12 h (A, B) and superior cervical sympathetic ganglia, exposure time 6 days (C, D). B and D are sections 
adjacent to A and C, respectively, stained with Toluidine blue. Arrows point to clusters of substance P binding sites (A, C) and 
to clusters of ganglion cells (B, D). [Reproduced with permission from Ref. 14.]
standard curves [In optical densities x 100 vs In disintegra-
tions per minute (dpm) of standards], as described in the 
section of Basic Methodology, the optical densities of the 
tissue areas studied are interpolated in the straight line to 
obtain the corresponding dpm bound to the tissue"'. 
Results are corrected for the decay of '9. Calculations of 
the molar quantities of ligand bound to the tissue, satura-
tion curves, and Scatchard analysis are performed by the 
use of the LIGAND computer program",'', followed by 
correction for the protein content of the standards. 
'251-Bolton-Hunter substance P binding sites 
 Using the receptor autoradiographic technique, specific 
binding sites for '251-Bolton-Hunter substance P, functional 
sites of NK, receptor predominantly recognizing substance 
P have been assayed in the central nervous system and 
peripheral organs. Taking advantage of this assay 
method, the binding sites in very small tissues such as rat 
sympathetic ganglia were localized and quantitated'4 . As 
shown in Fig. 3, nodular and heterogeneous distributions
of the binding sites in the superior cervical sympathetic 
ganglion (A in the figure) and celiac-superior mesenteric 
sympathetic ganglion (C) were detected. When compared 
with the adjacent sections stained by Toluidine blue, 
125I-Bolton-Hunter substance P binding sites were located in 
the areas of high density of principal ganglion cells (cell 
bodies of the postganglionic noradrenergic neurons) both 
in the ganglia (B and D). The superior and celiac ganglia 
had a single class of binding sites with Kds (dissociation 
constants) of 0.49 nM and 0.58 nM, respectively. As nerve 
endings of primary sensory neurons containing substance P 
originating from the dorsal root ganglia have been seen 
surrounding principal ganglion cells'), the existence of 
specific 1I-Bolton-Hunter substance P binding sites sup-
ports the excitatory modulation of substance P on the 
ganglionic transmission between the pre- and postgan-
glionic sympathetic neurons. 
 We also detected the binding sites in the human skin 
tissues, pad skin obtained from a thumb excised from a 
12-month-old boy with polydactylia'7 . The highest density 
of 1I-Bolton-Hunter substance P binding sites was noted
Fig. 4. Receptor autoradiographic evidence of "I-Bolton-Hunter substance P binding sites in the finger pad skin obtained 
from a thumb excised from a 12-month-old boy with polydactylia (A), and from a rat paw pad skin (B). Consecutive, 16,u m 
thick tissue sections were incubated with 100 pM of the radio-labeled ligand, without (middle panel) and with 1.0'" M of 
unlabeled substance P for non-specific binding (lower panel). Dried sections were exposed to 3H-Ultrofilm for 4 days. Adjacent 
sections were stained with hematoxylin-eosin to observe the anatomy (upper panel). DP, dermal papilla ; SG, sweat gland. 
Bar = 1.0 mm. [Reproduced with permission from Ref. 17.]
in the dermal papilla and sweat gland (Fig. 4). The binding 
to the dermal papilla was of single and high affinity with 
a Kd of 744 pM. Of particular interest is the observation 
that the highest density of the binding sites was in the 
dermal papilla, an area which contains substance P-
containing free ending, in addition to the nerve endings 
innervating capillaries'). In this study, light microscopic 
examination of emulsion autoradiography revealed that 
the 1251-Bolton-Hunter substance P binding in the dermal 
papilla of the human thumb pad skin did not only over the 
vascular endothelial cells, but also in the areas devoid of 
vascular component (data not shown). As the free nerve 
endings are nociceptors related to the transmission of 
paint's), evidence for the existence of the binding sites in an 
area of the dermal papilla which lacks the vascular compo-
nent seems pertinent to the proposal that the binding sites 
are presynaptic receptors on the free nerve endings and 
may relate to pain transmission.
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